Series & Collections
Our collections connect evidence and lived experience over time—building practical understanding across people, partnerships, systems, innovation, equity and impact.
Collection
Part 2 of 3
From Medway and Kent to Liverpool and the South West, BloomShield Local Lens is beginning to reveal different kinds of breast screening inequality. The next question is not simply whether gaps exist — but what they are, why they occur, and how widespread they really are.
Read the full Insight →
Part 1 of 3
Recognising the people behind breast cancer prevention and screening — and asking why too many women are still not reaching services already available to them.
Read the full Insight →
Conversations Across the Cancer Care Ecosystem
What it will take to build resilient diagnostic ecosystems across Africa.
With Olusola “Shola” Ogunbowale · Interviewed by Dr Femi Olaleye
The foundational BloomShield Insights archive: an eight-part series and a final handover essay on building partnerships capable of advancing equitable cancer care.
Local Lens
A recurring national series examining what local cancer data shows, who may still be getting missed, and how community and system partners can respond.
First edition · Medway & Kent
BloomShield Local Lens begins in Medway and Kent, examining screening progress, the inequality gaps beneath local averages, and how community and system partners can respond.
Edition 02 · Liverpool
Local data. Local voices. Local action. When screening exists but people still don’t get screened — what Liverpool can teach us.
Edition 03 · Devon, Cornwall & the Isles of Scilly
Strong overall screening performance can still hide local inequality.
Edition 04 · West London
West London combines world-class cancer infrastructure with some of the lowest breast screening participation in England. The question is not simply whether services exist — but whether proximity is converting into participation.
Edition 05 · Greater Manchester
Greater Manchester is showing that screening inequalities are not fixed — and that targeted, personalised support can change participation and pathway outcomes.
Evidence & Policy
We examine whether policy reaches the people it is intended to serve—and what implementation requires next.
NHS England’s national offer could remove an important barrier to screening. Its impact will depend on whether under-screened women complete the pathway from invitation to follow-up.
By Dr Femi Olaleye
Explore our analysis of NHS HPV self-testing in England
Australia is moving towards cervical cancer elimination. The real lesson for the world is how vaccination, screening, data, follow-up and policy were connected into a system.
By Dr Femi Olaleye
Explore Australia’s elimination story
A careful look at County Durham’s historic breast-services review, the changes the Trust reports making, and what clinical audit, implementation and evaluation can teach health systems.
By Dr Femi Olaleye
Read the full InsightA grounded view of promising tools and models: the systems they enter, the people who deliver them and the evidence needed to scale.
The collection will grow here
